Morgan Stanley anticipates that a slow start to the capital markets this year will push a rebound in activity into coming ...

Mineralys Therapeutics (MLYS) announced that it has commenced an underwritten public offering of $250M of shares of its common stock. Mineralys ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

Today, Benzinga 's options scanner spotted 32 uncommon options trades for Biogen. This isn't normal. The overall sentiment of these big-money traders is split between 37% bullish and 31%, bearish. Out ...

With inflation likely to remain elevated, analysts expect Fed officials to hold interest rates steady at the current range of ...

Walgreens Boots Alliance (Nasdaq: WBA) has entered into a definitive agreement to be acquired by an entity affiliated - ...

Officials have spent the past several days bracing Americans for a slowdown that they say will lead to stronger growth ahead.

In a report released today, Ebrahim Poonawala from Bank of America Securities maintained a Buy rating on Bank of New York Mellon Corporation ...

Goldman Sachs is doubling down on Dallas as it prepares to open an 800,000-square-foot campus in the city. Why it matters: ...

TD Cowen downgraded shares of BorgWarner (NYSE:BWA – Free Report) from a buy rating to a hold rating in a research note ...